Literature DB >> 14576592

[EVE, a regional campaign for the screening of cervical cancer. Organization, 7-years results and perspectives].

M Fender1, J Schott, J-J Baldauf, J Muller, E Schlund, P Dellenbach.   

Abstract

OBJECTIVE: Based on the 7-years results, assess the interest of organised cervical cancer screening on regional level (the EVE campaign). ORGANISATION AND
METHOD: The screening relied on existing medical structures. The centralised data collection, with data from the cyto-pathology laboratories assessed the quality of screening and the participation of the women to the follow-up of abnormal smears. The campaign run by a local women's rights association and sponsored by National educational and health information funds (FNPEIS) and the local councils.
RESULTS: To date, 814 649 smears in the Bas-Rhin and 62 227 in the Haut-Rhin have been collected. After 3 years, 72% of women aged 25 to 64 in the year 1997, in the Bas-Rhin, had had at least one smear, and 82% after 5 years. Inadequate smears represented less than 1% of all smears of the region. Pathological smears represented around 4% of the total and benefited from strict monitoring which could be improved. However this could be improved on since only 75% of women in whom a low-grade lesion was suspected underwent a second examination within the year that followed. The rate was on 80% for those with suspected high-grade lesions. Reminders made by the EVE association, in agreement with practitioners, permitted postponed follow-up and improved screening coverage.
CONCLUSION: The EVE programme clearly shows that organized screening is feasible in France because the results obtained are satisfactory in terms of screening coverage and quality of smears. Centralised data collection permits detection of possible weak points and contributes to the improvement in efficacy.

Entities:  

Mesh:

Year:  2003        PMID: 14576592

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

1.  Cost-effectiveness of two-dose human papillomavirus vaccination in Singapore.

Authors:  Sun Kuie Tay; Bee-Wah Lee; Woo Yun Sohn; I-Heng Lee; Gaurav Mathur; Melvin Sanicas; Georges Van Kriekinge
Journal:  Singapore Med J       Date:  2017-10-06       Impact factor: 1.858

2.  Comparative Cost-Effectiveness Analysis of Two Different Two-Dose Human Papillomavirus Vaccines in Malaysia

Authors:  Georges Van Kriekinge; Woo-Yun Sohn; Syed Mohamed Aljunid; Ruey Soon; Chee-Meng Yong; Jing Chen; I-Heng Lee
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.